Cargando…

The role of B-type natriuretic peptide in diagnosing acute decompensated heart failure in chronic kidney disease patients

INTRODUCTION: Chronic kidney disease (CKD) and congestive heart failure (CHF) patients have higher serum B-type natriuretic peptide (BNP), which alters the test interpretation. We aim to define BNP cutoff levels to diagnose acute decompensated heart failure (ADHF) in CKD according to CHF subtype: he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadri, Amer N., Kaw, Roop, Al-Khadra, Yasser, Abuamsha, Hasan, Ravakhah, Keyvan, Hernandez, Adrian V., Tang, Wai Hong Wilson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111357/ https://www.ncbi.nlm.nih.gov/pubmed/30154881 http://dx.doi.org/10.5114/aoms.2018.77263

Ejemplares similares

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Admissional B-type natriuretic peptide is an independent predictor of outcome in patients with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2003)

Accuracy of B-natriuretic peptide for the diagnosis of decompensated heart failure in muscular dystrophies patients with chronic respiratory failure
por: Meng, Paris, et al.
Publicado: (2018)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Causes and Predictors of 30‐Day Readmission in Patients With Syncope/Collapse: A Nationwide Cohort Study
por: Kadri, Amer N., et al.
Publicado: (2018)

The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population
por: Chen, Li Juen, et al.
Publicado: (2016)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?
por: Golabchi, Allahyar
Publicado: (2012)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

The utility of B-type natriuretic peptide in differentiating decompensated heart failure from lung disease in patients presenting to the emergency department with dyspnea
por: Villacorta, H, et al.
Publicado: (2003)

Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with differsent blood BNP levels
por: Pan, Hai-Yan, et al.
Publicado: (2014)

Relationship between B-type natriuretic peptide plasma levels and echocardiography parameters in decompensated chronic heart failure patients treated with levosimendan
por: Ferri, MB, et al.
Publicado: (2006)

Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure
por: Yoon, Jae Yong, et al.
Publicado: (2019)

B-type natriuretic peptide/ferritin ratio as a predictor of the risk of developing acute renal injury in acute decompensated heart failure
por: Ceyhun, Gökhan, et al.
Publicado: (2021)

Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report
por: Tiepolo, Ambre, et al.
Publicado: (2019)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure
por: Nathanson, David, et al.
Publicado: (2016)

Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure
por: Noveanu, Markus, et al.
Publicado: (2011)

Point of care with serial N-terminal pro-B-type natriuretic peptide (NT-proBNP) for heart failure in patients with acute decompensation. An invited commentary
por: Sergi, Consolato M.
Publicado: (2022)

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
por: Jafri, Lena, et al.
Publicado: (2013)

Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels
por: Valle, Roberto, et al.
Publicado: (2011)

Acute Kidney Disease After Acute Decompensated Heart Failure
por: Chen, Jia-Jin, et al.
Publicado: (2022)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Unrecognized Pulmonary Hypertension in Non-Cardiac Surgical Patients: At-Risk Populations, Preoperative Evaluation, Intraoperative Management and Postoperative Complications
por: Kaw, Roop K.
Publicado: (2023)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Metastatic Clear Cell Renal Cell Carcinoma Presenting as Acute Appendicitis
por: Ushakova, Oxana, et al.
Publicado: (2023)

Massive Calcified Abdominal Aortic Aneurysm Presenting as Low Back Pain
por: Ushakova, Oxana, et al.
Publicado: (2023)

Plasma levels of natriuretic peptides and development of chronic kidney disease
por: Ogawa, Noriyuki, et al.
Publicado: (2015)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Taipan Natriuretic Peptides Are Potent and Selective Agonists for the Natriuretic Peptide Receptor A
por: Vink, Simone, et al.
Publicado: (2023)

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial
por: Maisel, Alan S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_iv4ng8pdijpgqvoasoit3v3lp3